Novo Group–Verlenden D: management, 202412– CEO of Single Use Support before Merck KGaA

	Period	2024-12-16
	Organisation	Single Use Support GmbH (SUS)
	Group	Novo Group (Group)
	Organisation 2	Merck KGaA
	Group	Merck (DE) (Group)
	Product	sample preparation / sample handling (excl liquid handling)
	Product 2	laboratory equipment and instruments
	Index term 2	Single Use Support–Novo Group: investment, 202405 acquisition of 60% majority share by Novo Holdings
	Person	Verlenden, Darren (Novo Group 202412– CEO of Single Use Support before Merck KGaA)
	Person 2	Praxmarer, Christian (Single Use Support 202405 CEO)

Single Use Support GmbH. (12/16/24). "Press Release: Darren Verlenden New CEO of Single Use Support". Kufstein.

Single Use Support Announces Darren Verlenden as CEO and Strengthens Leadership Team for Further Growth and Global Expansion.

Single Use Support, a leading provider of innovative fluid management and cold chain solutions for the biopharmaceutical industry, is pleased to announce the appointment of Darren Verlenden as Chief Executive Officer, effective immediately. This strategic move, along with key additions to the leadership team, underscores the company's commitment to driving forward its ambitious global growth plans.

Prior to this appointment Darren was the Executive Vice President for the Process Solutions business of Merck KGaA Darmstadt Germany. He brings 20+ years of knowledge and expertise to the company, through his extensive experience in the Life Science manufacturing sector.

In his new role, Darren will be responsible for driving the growth strategy and expansion of Single Use Support's global commercial and operational footprint. "I am excited to join such a talented team and help Single Use Support embark on the next phase of its growth trajectory” said Verlenden. “The portfolio has exceptional differentiated value, and a strong history of delivering innovative solutions that meet the evolving needs of our clients."

Managing Director Christian Praxmarer is confident that Darren will leverage his expertise to strengthen the company’s market position: “His commercial leadership and strategic development skills will be invaluable in deepening Single Use Support's commitment to quality and innovation.” Christian will continue to be an instrumental part of the Single Use Support leadership team in his role as Chief Operating Officer, based in Kufstein.

Johan Hueffer, Senior Partner, Principal Investments at Novo Holdings said, “We are delighted to welcome Darren to the Single Use Support team. He is a dynamic global leader with highly relevant experience, and an excellent fit to the Single Use Support organization. We look forward to working with him to continue to grow the business and deliver long-term value for our customers and shareholders.”

Further key additions to the team and advisory board

In addition to the CEO appointment Single Use Support has continued to strengthen its executive team with the recent hire of industry veteran Ulrike Lemke as Chief Commercial Officer. Ulrike has previously held senior positions in commercial and manufacturing operations at Lonza, Sartorius and most recently Recipharm. Both key leadership appointments are designed to accelerate the global presence of Single Use Support as a key player in the life sciences sector.

In addition, two senior independent directors have joined the Advisory Board of Single Use Support.

Meeta Gulyani, with extensive experience spanning commercial, strategy and M&A across Pharmaceutical and Life Science industries, including Sanofi, Roche, Merck KGaA and recently appointed as Head of Life Science Strategy and General Manager – Bioprocessing at Ecolab, will contribute her tremendous expertise and connectivity in the space.

Stefan Stoffel, formerly Chief Operating Officer at Lonza, brings vast knowledge and decades of experience of operations and manufacturing excellence in the bioprocessing industry.

With the completion of its top management and broadening of the Advisory Board, Single Use Support is now well positioned to take the next step in its success story as it collaborates with biopharmaceutical clients to achieve quality outcomes.

About Single Use Support

Single Use Support is a pioneering process solution provider specializing in fluid and cold chain management of drug substances. Headquartered in Austria, the pioneering company focuses on the development of process solutions to provide manufacturers with 100% safe and efficient handling, liquid transfer, freezing and cold chain shipping of advanced therapies and biologics in pharmaceutical production.
For more information about Single Use Support and its innovative products, please visit www.susupport.com

Press release online: https://www.susupport.com/company/news/darren-verlenden-single-use-support

Contact

Single Use Support
Michael Mühlegger
Head of Marketing & Inside Sales
Endach 36
6330 Kufstein
+43 664 60043204
[email protected]